Support Us — Your donation helps us keep running

Goal: 1000 CNY,Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2019-3582
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
McAfee Endpoint Security updates fix a privilege escalation vulnerability
Source: NVD (National Vulnerability Database)
Vulnerability Description
Privilege Escalation vulnerability in Microsoft Windows client in McAfee Endpoint Security (ENS) 10.6.1 and earlier allows local users to gain elevated privileges via a specific set of circumstances.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
McAfee Endpoint Security 后置链接漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
McAfee Endpoint Security(ENS)是美国迈克菲(McAfee)公司的一套提供智能协作和先进的威胁防御的框架。该框架支持对实时通信的整个威胁防御生命周期进行控制并进行可操作的威胁取证等。 McAfee ENS 10.6.1及之前版本中的Microsoft Windows客户端存在后置链接漏洞。本地攻击者可利用该漏洞获取提升的权限。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
McAfee, LLCMcAfee Endpoint Security (ENS) 10.5.3 ~ 10.5.3 Hotfix 1240838 -
II. Public POCs for CVE-2019-3582
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2019-3582
Please Login to view more intelligence information
New Vulnerabilities
V. Comments for CVE-2019-3582

No comments yet


Leave a comment